Description:

Southwest Oncology Group Off Treatment Notice NCT00499369 Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=1540B168-F57F-6FA2-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=1540B168-F57F-6FA2-E044-0003BA3F9857

Keywords:
Versions (3) ▾
  1. 8/27/12
  2. 1/8/15
  3. 6/3/15
Uploaded on:

June 3, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Southwest Oncology Group Off Treatment Notice NCT00499369

No Instruction available.

  1. StudyEvent: Southwest Oncology Group Off Treatment Notice
    1. No Instruction available.
SWOG clinical trial administrative data
Vital Status
Protocol treatment
Did the patient receive any protocol treatment (on this registration step)
Off protocol treatment
Off Treatment Reason (select one:)
Was treatment termination medically required (For any adverse event,)
Was reason due to adverse event/side effects/complications (For any patient refusal,)
Further treatment
Will patient receive further treatment?
Comments

Similar models